Theralase Technologies Inc. V.TLT

Excellent News

[knoxt]

 

 

Theralase® (TSXV: TLT) has commenced a Listed Issuer Financing Exemption (“LIFE”) private placement financing for up to $CAN 5.3 M. Theralase(R) Announces Brokered LIFE Financing (tmx.com)

 

The Company is focused on providing the next standard of care treatment for bladder cancer (10^th most common cancer in the world, 6^th in men) which represents a potential market opportunity of approximately $USD 1 to 7 B annually. 

 

Why Theralase®

 

• Theralase is developing a paradigm-shifting Photo Dynamic Therapy (“PDT”) for treating BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (“NMIBC”) Carcinoma In-Situ (“CIS”).
• On October 16^th, the Company announced encouraging results with 65% of patients treated in the Phase-II pivotal trial achieving Complete Response (“CR”). Theralase(R) Provides Update on Bladder Cancer Clinical Study (tmx.com)
• On October 23^rd, the Company optimized the design of the Phase II clinical study. Theralase(R) Optimizes Phase II Bladder Cancer Clinical Study (tmx.com)
• The Company enrolled and treated 63 out of 100 patients in an FDA Phase II clinical study; potentially granting Theralase® access to a cancer market worth $USD 1 to 7 billion annually, if regulatory approved
• Interim data to date is trending better than current FDA approved treatments, Keytruda® (Pembrolizumab) and Adstiladrin®
• Theralase® expects to apply for pre-Breakthrough Therapy Designation (“BTD”) before year end.

 

 

Terms:

 

 

• Offer: LIFE offering for up to $5.3mm, $0.22 per Unit (1 common share + 1 full 5 year warrant; exercisable at $0.28 for 5 years)
• Best efforts to list the warrant

 

 

If you wish to participate, please e-mail [e-mail] to receive the Investor Questionnaire for completion.

 

Note: For US-based retail investors, the LIFE exemption would not apply and there would be a 4 month hold on the common shares and warrants.

 

Note: Unfortunately, Quebec-based investors are not eligible for this LIFE financing.

[Legit62]

whats the great news Knoxt?? were they able to fill it??

[Eoganacht]

The great news is that Theralase has confirmed they will submit the BTD application before year end, they are now plainly stating that Ruvidar PDT is better than both FDA approved treatments Keytruda and Adstiladrin, and they treated one more patient. Just 37 patients to go.

[riverrrow]

The great news is that it looks like the LIFE financing is still open and almost anyone can participate.  Normally in a pp you have to be an accredited investor with liquid assets of at least  one million dollars.  It looks like in the LIFE financing all us keyboard warriors can put our money where our mouths are.  There might be a $5,000 or $10,000 minimum, ask Roger. 

[StevenBirch]

I was thinking (hoping?) this was a bone thrown to us regular folks after a few non-brokered PP's sold I assume to 'friends'. If so that could be a sign this is it for the cheap financings.

[gonefishing2022]

I Put in for 2500 Dollars 

[Beano349]

It said Pre BTD not just BTD so they pushed the timeliness again, although just slightly. 

[N0taP00p]

Eoganacht: You're one of the trusted voices here.  Did you mean pre-BTD submission or BTD submission by year end?  I'm not surprised if they pushed again without explicitly saying so. It's all moot if they can't raise money. 

[BudFoxx2020]

Lol @ trusted voice.   There is a whole news release out today.  Just put in a little time to do some research and due dilligence.  Cheers.     https://stockhouse.com/opinion/interviews/2023/11/06/theralase-raising-up-to-5-3m-to-complete-bladder-cancer-study   Over the next six months the company is working on a pre-breakthrough designation approval for the

[Eoganacht]

It's pre-BTD submission by year end. I misread the email announcement.

[99942Apophis]

Most of you already know progress of each new Pre-BTD brings us to where FDA  says yes its what we require please apply for BTD.  What we don’t know has that "final" Pre-BTD been sent or will it be sent in November,  perhaps the end of November update will give clarity, either way we all know it is near!

[BudFoxx2020]

This is where the whole misunderstandings started today.   No where in the interview or email did the company confirmed they will submit BTD application before the end of the year.  In the interview RWD says they hope to have the Pre BTD submission in over the next 6 months and in the email the company said they EXPECT to apply for pre BTD before year end.  See how one post can

[stocksnbonds458]

Eoganacht they haven't "confirmed" pre BTD  submission by December whatsoever, the wording was "expects to". This is the same expectation the company has had since July of this year, the process is a jungle of red tape and clinical trial rules/regulations that has slowed the process considerably. We will eventually get there, but man it takes patience!!

[BudFoxx2020]

Looks like the LIFE financing didn't even fill the minimum required.  This offering is supposed to close on the week of Oct 30.  The offering will only close if it meets the minimum required.  I am surprised RCC didn't just fill the rest themselves.  Only 3 million dollars, for a big player like RCC, that is chump change.  I mean RCC has a price target for TLT at 0

[N0taP00p]

What news are you all referring to. I don't see any NRs yet. 

[Legit62]

Same here NOtap00p

[rhodiumd]

It wasn't an official NR.  Theralase sent out an email blast to their newsletter subscriber list earlier this morning . They basically sent the same content that was released via NR a couple weeks ago. Sign up to their newsletter on their website to receive the next ones.

[N0taP00p]

Thanks Rhodium. I guess they are struggling to fill the minimum then.  This close and yet so far. At this point, I'm considering any kind of returns on this stock as a lucky lottery ticket, with a self reminder to never again invest in any Canadian startups without a lot more DD. SesenBio, Titan Medical, Sona Nanotech and a few others that i took a chance on. All great ideas. That's

[Alamir1111]

Tmd had a 5.66 $high. Sesn&sona 13$ high?did you sell early?

[reconsider]

Excellent news would have been an already closed PP with 5M in the bank, not an email blast trying to lure newsletter subscribers. Not looking good... and now Q4 BTD submission turned into Pre-BTD... Neverending story.

[Alamir1111]

Rdw is on market place interview 

[Dumbeldorfwhite]

Shhhh people around here don't want to hear it

[rhodiumd]

With inflation, market conditions, fears (wars and recession), and record household and credit card debt, the timing of the raise is definitely not perfect but it is what Theralase needs to bring this drug to market. They don't just have good numbers, they have best-in-class, record breaking efficacy and safety numbers. This will be the best drug on the market once it is commercialized. 

[DeathXray33]

Are any of you nice folks friends with Benny? If not, I wish him well...